Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding
- Widen, Elizabeth M.
- Bentley, Margaret E.
- Chasela, Charles S.
- Kayira, Dumbani
- Flax, Valerie L.
- Kourtis, Athena P.
- Ellington, Sascha R.
- Kacheche, Zebrone
- Tegha, Gerald
- Jamieson, Denise J.
- van der Horst, Charles M.
- Allen, Lindsay H.
- Shahab-Ferdows, Setareh
- Adair, Linda S.
Publication date
January 2015
DOIAbstract
In resource-limited settings without safe alternatives to breastfeeding, the WHO recommends exclusive breastfeeding and antiretroviral (ARV) prophylaxis. Given the high prevalence of anemia among HIV-infected women, mothers and their infants (via fetal iron accretion) may be at risk of iron deficiency. We assessed the effects of maternal micronutrient-fortified lipid-based nutrient supplements (LNS) and maternal ARV treatment or infant ARV prophylaxis on maternal and infant iron status during exclusive breastfeeding from birth to 24 weeks
Add to ORKG